I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-40.17%
Change (1 year)
Categories
EPS for I-Mab Biopharma (IMAB)
EPS in 2020 (TTM): $1.38
According to I-Mab Biopharma's latest financial reports the company's current EPS (TTM) is $1.38. In 2021 the company made an earnings per share (EPS) of -$4.82 a decrease over its 2020 EPS that were of $1.24.
EPS history for I-Mab Biopharma from 2017 to 2020
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2021 | -$4.82 | -489.3% |
| 2020 | $1.24 | -133.67% |
| 2019 | -$3.68 | 179.42% |
| 2018 | -$1.32 | 27.77% |
| 2017 | -$1.03 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -119.61% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -172.62% | 🇺🇸 USA |